Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104499791> ?p ?o ?g. }
- W2104499791 endingPage "537" @default.
- W2104499791 startingPage "528" @default.
- W2104499791 abstract "Accurate prognosis is a key factor in establishing optimal therapeutic decisions; yet in the case of bladder cancer (BlCa) current prognostic indicators cannot ensure optimal disease management. Here, we aimed to evaluate the previously unexplored clinical potential of the urological cancer-related miR-145, miR-143 and miR-224 in BlCa. A total of 279 bladder tissue specimens were included in this study (133 BlCa, 107 adjacent normal and 39 healthy samples). Total RNA was extracted from tissues, it was polyadenylated and reverse transcribed to cDNA. The expression of target molecules was measured via quantitative real-time PCR. The expression levels of both miR-143 and miR-145 were significantly decreased, whereas those of miR-224 were increased in BlCa. Receiver operating characteristic curve analysis indicated a significant discriminatory capacity for miR-143/miR-145 levels. Important associations with disease aggressiveness were observed for all three microRNAs; elevated levels were observed in tumors of higher stage and grade, as well as in 'high-risk' TaT1 patients. More importantly, high miR-143/145 levels could effectively prognose inferior overall survival for muscle-invasive patients and could independently predict the progression of superficial tumors. Finally, the combination of miR-143/145 overexpression with the widely used prognostic markers of European Organization for Research and Treatment of Cancer-risk groups or recurrence at the first follow-up cystoscopy resulted to a superior positive prediction of non-muscle-invasive bladder cancer short-term progression compared with the use of the abovementioned markers alone. The cancer-related miR-143, miR-145 and miR-224 were investigated for the first time in the clinical setting of BlCa, and miR-143/145 cluster constitutes a novel marker helpful for providing an enhanced prediction of oncologic outcome for BlCa patients." @default.
- W2104499791 created "2016-06-24" @default.
- W2104499791 creator A5011440448 @default.
- W2104499791 creator A5025871210 @default.
- W2104499791 creator A5060303041 @default.
- W2104499791 creator A5068727435 @default.
- W2104499791 creator A5084668769 @default.
- W2104499791 creator A5085601430 @default.
- W2104499791 date "2015-03-24" @default.
- W2104499791 modified "2023-10-16" @default.
- W2104499791 title "Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment" @default.
- W2104499791 cites W144423133 @default.
- W2104499791 cites W1560239325 @default.
- W2104499791 cites W1648301895 @default.
- W2104499791 cites W1933236632 @default.
- W2104499791 cites W1968252785 @default.
- W2104499791 cites W1970583256 @default.
- W2104499791 cites W1975437957 @default.
- W2104499791 cites W1980458049 @default.
- W2104499791 cites W1982343022 @default.
- W2104499791 cites W1989498301 @default.
- W2104499791 cites W1991034124 @default.
- W2104499791 cites W1992920916 @default.
- W2104499791 cites W1995630283 @default.
- W2104499791 cites W1997683783 @default.
- W2104499791 cites W1998129534 @default.
- W2104499791 cites W2002045993 @default.
- W2104499791 cites W2002995168 @default.
- W2104499791 cites W2009474879 @default.
- W2104499791 cites W2014177368 @default.
- W2104499791 cites W2014610388 @default.
- W2104499791 cites W2018561776 @default.
- W2104499791 cites W2020780443 @default.
- W2104499791 cites W2034608727 @default.
- W2104499791 cites W2037090973 @default.
- W2104499791 cites W2039609330 @default.
- W2104499791 cites W2040752756 @default.
- W2104499791 cites W2045692024 @default.
- W2104499791 cites W2064561270 @default.
- W2104499791 cites W2067053182 @default.
- W2104499791 cites W2073118251 @default.
- W2104499791 cites W2076439746 @default.
- W2104499791 cites W2078744748 @default.
- W2104499791 cites W2080922093 @default.
- W2104499791 cites W2081158187 @default.
- W2104499791 cites W2091166689 @default.
- W2104499791 cites W2092050888 @default.
- W2104499791 cites W2099692224 @default.
- W2104499791 cites W2106787323 @default.
- W2104499791 cites W2107277218 @default.
- W2104499791 cites W2108132199 @default.
- W2104499791 cites W2111471857 @default.
- W2104499791 cites W2114557056 @default.
- W2104499791 cites W2128092062 @default.
- W2104499791 cites W2135924442 @default.
- W2104499791 cites W2136757828 @default.
- W2104499791 cites W2146278947 @default.
- W2104499791 cites W2151781453 @default.
- W2104499791 cites W2152241304 @default.
- W2104499791 cites W2152455106 @default.
- W2104499791 cites W2155445572 @default.
- W2104499791 cites W2158243950 @default.
- W2104499791 cites W2162097274 @default.
- W2104499791 cites W2164812888 @default.
- W2104499791 cites W2167203269 @default.
- W2104499791 cites W2327362588 @default.
- W2104499791 doi "https://doi.org/10.1093/carcin/bgv024" @default.
- W2104499791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25804644" @default.
- W2104499791 hasPublicationYear "2015" @default.
- W2104499791 type Work @default.
- W2104499791 sameAs 2104499791 @default.
- W2104499791 citedByCount "62" @default.
- W2104499791 countsByYear W21044997912015 @default.
- W2104499791 countsByYear W21044997912016 @default.
- W2104499791 countsByYear W21044997912017 @default.
- W2104499791 countsByYear W21044997912018 @default.
- W2104499791 countsByYear W21044997912019 @default.
- W2104499791 countsByYear W21044997912020 @default.
- W2104499791 countsByYear W21044997912021 @default.
- W2104499791 countsByYear W21044997912022 @default.
- W2104499791 countsByYear W21044997912023 @default.
- W2104499791 crossrefType "journal-article" @default.
- W2104499791 hasAuthorship W2104499791A5011440448 @default.
- W2104499791 hasAuthorship W2104499791A5025871210 @default.
- W2104499791 hasAuthorship W2104499791A5060303041 @default.
- W2104499791 hasAuthorship W2104499791A5068727435 @default.
- W2104499791 hasAuthorship W2104499791A5084668769 @default.
- W2104499791 hasAuthorship W2104499791A5085601430 @default.
- W2104499791 hasConcept C104317684 @default.
- W2104499791 hasConcept C121608353 @default.
- W2104499791 hasConcept C126322002 @default.
- W2104499791 hasConcept C143998085 @default.
- W2104499791 hasConcept C145059251 @default.
- W2104499791 hasConcept C146357865 @default.
- W2104499791 hasConcept C151730666 @default.
- W2104499791 hasConcept C2778769751 @default.
- W2104499791 hasConcept C2779134260 @default.
- W2104499791 hasConcept C2780352672 @default.